Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011

GlobalData, August 2011, Pages: 129

Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2011" provides data on the Benign Prostatic Hyperplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Benign Prostatic Hyperplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Benign Prostatic Hyperplasia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables
List of Figures
Introduction
Benign Prostatic Hyperplasia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Benign Prostatic Hyperplasia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Benign Prostatic Hyperplasia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Sanofi
Clinical Trial Overview of Sanofi
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
Health Ever Bio-Tech Co., Ltd.
Clinical Trial Overview of Health Ever Bio-Tech Co., Ltd.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Watson Pharmaceuticals, Inc.
Clinical Trial Overview of Watson Pharmaceuticals, Inc.
Nymox Pharmaceutical Corporation
Clinical Trial Overview of Nymox Pharmaceutical Corporation
AEterna Zentaris Inc.
Clinical Trial Overview of AEterna Zentaris Inc.
Allergan, Inc.
Clinical Trial Overview of Allergan, Inc.
QLT Inc.
Clinical Trial Overview of QLT Inc.
American Medical Systems Holdings, Inc.
Clinical Trial Overview of American Medical Systems Holdings, Inc.
Light Sciences Oncology, Inc.
Clinical Trial Overview of Light Sciences Oncology, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Threshold Pharmaceuticals, Inc.
Clinical Trial Overview of Threshold Pharmaceuticals, Inc.
Teva Pharmaceuticals USA, Inc.
Clinical Trial Overview of Teva Pharmaceuticals USA, Inc.
Spectrum Pharmaceuticals, Inc.
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
Kissei Pharmaceutical Co., Ltd.
Clinical Trial Overview of Kissei Pharmaceutical Co., Ltd.
Ferring Pharmaceuticals
Clinical Trial Overview of Ferring Pharmaceuticals
Sun Pharmaceutical Industries Limited
Clinical Trial Overview of Sun Pharmaceutical Industries Limited
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
Hospital Authority
Clinical Trial Overview of Hospital Authority
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
The International Kidney Stone Institute
Clinical Trial Overview of The International Kidney Stone Institute
The University of Tokyo Hospital
Clinical Trial Overview of The University of Tokyo Hospital
Asan Medical Center
Clinical Trial Overview of Asan Medical Center
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
Northwestern University
Clinical Trial Overview of Northwestern University
University of Alberta
Clinical Trial Overview of University of Alberta
Hospices Civils de Lyon
Clinical Trial Overview of Hospices Civils de Lyon
University of Washington
Clinical Trial Overview of University of Washington
University of Missouri
Clinical Trial Overview of University of Missouri
Southwest Hospital, China
Clinical Trial Overview of Southwest Hospital, China
Weill Cornell Medical College
Clinical Trial Overview of Weill Cornell Medical College
Chinese University of Hong Kong
Clinical Trial Overview of Chinese University of Hong Kong
Queen's University
Clinical Trial Overview of Queen's University
Lawson Health Research Institute
Clinical Trial Overview of Lawson Health Research Institute
Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, G7 Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, E7 Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Ever Bio-Tech Co., Ltd., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Watson Pharmaceuticals, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nymox Pharmaceutical Corporation, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by American Medical Systems Holdings, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kissei Pharmaceutical Co., Ltd., 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Hospital, China, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2011-

List of Figures
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, G7 Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, E7 Countries (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Methodology

Customers who bought this item also bought

• Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms (Event Driven)
• Epidemiology: Benign Prostatic Hyperplasia - Expected to continue growing as the male population ages
• Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future
• Nephrology and Urology Devices Market – Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018
• Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
• Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth
• DRG Insights: Benign Prostate Hyperplasia (G7)
• Minimally Invasive BPH and Prostate Cancer Treatment Devices Markets Worldwide
• Clinical Trial Management Systems (CTMS) - Global Strategic Business Report
• 2012 Good Clinical Practice: A Question & Answer Reference Guide